Subscribe to our Email Alerts

Scientific Presentations

4-Apr-2013
Poster at American Neuropsychiatric Association 2013 Annual Meeting

The Impact of NNZ-2566 on the fmr1 Knockout Mouse Model of Fragile X Syndrome

1-Aug-2012
Presentation by Dr Mike Snape at ICare4Autism 2012 International Autism Conference

NNZ-2566 - Rationale for use in Autism Spectrum Disorders

Quick Links

Contact Us

Neuren Pharmaceuticals Limited
Suite 201, 697 Burke Road
Camberwell, VIC 3124
Australia

Phone: +61 (3) 9092 0480
Email: enquiries@neurenpharma.com

Email Alerts

Subscribe to our Email Alerts

Follow Us

Copyright © Neuren Pharmaceuticals
Site Map Privacy Search
Site by